Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joshua Rhodenizer

Podiatrist, Foot & Ankle Surgery Detroit, MI Doctor of Podiatric Medicine

NPI 1720305501 CMS profile 123325

22101 Moross Rd, Suite 335, Detroit, MI 48236

Open in the dashboard

General payments

$9,201

146 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joshua Rhodenizer of Detroit, MI is reported in the CMS Open Payments database as having received $9,201 across 146 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $981 24
2024 General $1,576 26
2023 General $632 17
2022 General $3,869 28
2021 General $1,138 25
2020 General $381 7
2019 General $624 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Rhodenizer
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Joshua Rhodenizer were reported at $981. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Joshua Rhodenizer Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $624 $389 $118–$1,406 $163
2020 $381 $191 $62–$691 $114
2021 $1,138 $329 $104–$1,341 $132
2022 $3,869 $419 $125–$1,611 $149
2023 $632 $377 $128–$1,164 $160
2024 $1,576 $394 $134–$1,168 $164
2025 $981 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $2,762 68 payments
  2. Pinnacle, Inc $2,658 15 payments
  3. Acumed LLC $451 8 payments
  4. Integra LifeSciences Corporation $417 9 payments
  5. Acera Surgical, Inc. $343 3 payments
  6. Urgo Medical North America, LLC $326 2 payments
  7. Zimmer Biomet Holdings, Inc. $234 3 payments
  8. Anika Therapeutics, Inc. $232 3 payments
  9. Horizon Therapeutics plc $221 3 payments
  10. Smith+Nephew, Inc. $203 2 payments
  11. Other $1,354 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,697 142 payments
  2. Education $2,504 4 payments
Products named General payments · program years 2019–2025
  1. ALLOGRAFT $489 9 payments
  2. ALLOWRAP $485 9 payments
  3. CITREFIX $461 8 payments
  4. AUGMENT INJECTABLE $381 6 payments
  5. OsteoMed $380 5 payments
  6. Restrata Wound Matrix $343 3 payments
  7. Integra Recon-Skin And Wound $340 7 payments
  8. Integra Recon-Skin And Wound $340 7 payments
  9. PRIMATRIX $340 7 payments
  10. Integra Recon-Skin And Wound $340 7 payments
  11. Other $6,307 132 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

43

Median for Podiatry: 160

Drug cost

$716

Median for Podiatry: $2,368

Branded share of claims

41.9%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 14 $515
Cephalexin Generic 11 $131
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $70

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$23,238

Medicare's payments for the services billed

Medicare patients

149

Average age 70

Services billed

330

77 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Diabetes 53%
Chronic kidney disease 42%
Heart failure 35%
Ischemic heart disease 34%
COPD 27%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record